Megnosis, a compound word of Medical and Gnosis, is a medical device manufacturing company established with the goal of leading the medical field with differentiated insight.
By developing world's first reactive-EEG technology for cognitive measurement and combining it with EEG technology, we have developed the world's best biomarker device for mild cognitive impairment (MCI), Alzheimer's disease, and Depression.
We also developed an Integrated Diagnosis & Treatment System
(2-in-1 system) that uses spontaneous-EEG and reactive-EEG for diagnosis and electrical stimulation for treatment. This device is a monitoring and training device that delays or prevents Alzheimer's disease and screens and alleviates mood & emotional disorder.
We aim for innovation in diagnosis, treatment and healthcare with our unique principles and differentiated technology that others have not seen through insights on brain and human.